Melissa Uppal

Doctor of Osteopathic Medicine,  Charité - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Biostatistics Data Science-Bioinformatics Grant Submission Admin and Customer Support Journal Manuscript

Areas Of Interest

Unit, Burn Muscles, Vocalis Behavior Test Ménière's Vertigo Tagmin BIBW-2992-MA2 Polyglutamic Acid Asian Soybean Rust D-Aspartate Immunologic Contraception Pathological Gamblings OMIM Syndromes, Myofascial Pain Connective Tissues E Coli Transcription Termination Factor Assistance, Public Psychoacoustical Disorders Tinea Versicolor Shorthand Vicarious Traumas Hypogonadism, Hypogonadotropic Orbital Pseudotumor Apolipoprotein A-2 Platelet Aggregation Scarpa Ganglion Electric Eel Plan, Prepaid Health Mutation, INDEL Antigen Processings Dehydrogenase, 3-Phosphoglycerate Cell Research, Embryo Febrile Convulsion Cyclooxygenase Lactosyl Ceramides Alkylated DNA Repair Protein Alkb Homolog 8 Canine oral papillomavirus Paralysis, Oculomotor

Professional Narrative

Dr. Melissa Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 1994
Medical Writer, Mayo Clinic 2004

Education

Doctor of osteopathic medicine, Harvard Medical School 2007
Doctor of medicine, Yale School of Medicine 2004

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :